This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Transgenic Inc., Crc Inc., Tokyo Metropolitan Government. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2015
Title: Masao Kawakita: Innovator in Colorectal Cancer Detection
Introduction
Masao Kawakita is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. With a focus on innovative methods and technologies, Kawakita has been awarded 2 patents for his groundbreaking work.
Latest Patents
Kawakita's latest patents include a method for detecting colorectal cancer in its early stages, specifically stages 0 to I. This method involves a tumor marker comprising diacetylspermine. Additionally, he has developed a method for evaluating the state of a tumor by reacting an antibody to diacetylspermine with a biological sample. This process allows for the detection of diacetylspermine and the evaluation of the tumor's state using the obtained detection results as an indicator. His work also includes the invention of an anti-diacetylspermine specific monoclonal antibody, which meets specific measuring conditions in an immunoreaction system.
Career Highlights
Throughout his career, Masao Kawakita has worked with various organizations, including Transgenic Inc. and the Tokyo Metropolitan Government. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in cancer detection technologies.
Collaborations
Kawakita has collaborated with notable colleagues such as Kyoko Hiramatsu and Koji Yamaguchi. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Masao Kawakita's innovative work in colorectal cancer detection exemplifies the impact of dedicated inventors in the medical field. His patents and collaborations highlight the importance of research and innovation in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile